CHARLES RIVER LABORATORIES INTERNATIONAL, INC.·4

May 12, 4:19 PM ET

Graves Paul W 4

4 · CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Filed May 12, 2026

Research Summary

AI-generated summary of this filing

Updated

Charles River (CRL) Director Paul W. Graves Receives Award

What Happened Paul W. Graves, a director of Charles River Laboratories International, Inc. (CRL), was granted an award on 2026-05-08 consisting of 1,438 restricted stock units (RSUs) valued at $177.62 per share, for a total grant value of $255,418. This was an equity award (acquisition), not a purchase or sale of existing shares; the RSUs are unvested and subject to a vesting schedule.

Key Details

  • Transaction date and terms: 05/08/2026 — 1,438 RSUs @ $177.62 per share (total value $255,418). Transaction code: A (award/acquisition).
  • Vesting: The RSUs are unvested; they vest upon the earlier of 05/08/2027 or the business day prior to the Company’s next annual meeting of shareholders (per filing footnote).
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Filing date/timeliness: Form 4 filed 05/12/2026; this falls within the standard two-business-day reporting window for Form 4 filings following a 05/08/2026 transaction.

Context

  • This was an equity grant (RSUs) typically used for director compensation or retention; RSUs do not represent immediately sellable shares until they vest.
  • Because this is a grant rather than an open-market purchase or sale, it should be viewed as compensation-related, not a direct market sentiment signal from the insider.

Insider Transaction Report

Form 4
Period: 2026-05-08
Transactions
  • Award

    Common Stock

    [F1]
    2026-05-08$177.62/sh+1,438$255,4182,384 total
Footnotes (1)
  • [F1]The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders.
Signature
/s/ Paul Graves|2026-05-12

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT